Package 69367-262-09

{"route": ["ORAL"], "spl_id": "e4d63fde-89fa-4570-9939-6f9f2cad56bf", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["4bd97421-1e0a-40a6-a66b-f5f14e827eb3"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (69367-262-09)", "package_ndc": "69367-262-09", "marketing_start_date": "20230214"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (69367-262-30)", "package_ndc": "69367-262-30", "marketing_start_date": "20230214"}], "brand_name": "Valacyclovir", "product_id": "69367-262_e4d63fde-89fa-4570-9939-6f9f2cad56bf", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "69367-262", "generic_name": "Valacyclovir", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20230214", "listing_expiration_date": "20261231"}